JP Morgan Reiterates Neutral on Athenahealth, Raises PT to $50

JP Morgan reiterated its Neutral rating on Athenahealth ATHN. At the same time, the rating agency raised its price target on the company's stock from $42 to $50. On Thursday, ATHN closed the day at $48.58. Its shares are surging in today's pre-market trading, rising 10.75% to stand around $53.80.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Price TargetReiterationAnalyst RatingsHealth CareHealth Care ServicesJP Morgan
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!